Trials / Completed
CompletedNCT00905879
Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging
Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients will be recruited from those who will undergo contrast enhanced MRI. Safety and tolerability will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gadobutrol (Gadovist, BAY86-4875) | Patients who will need to undergo contrast enhanced MRI with gadobutrol (Gadovist) |
Timeline
- Start date
- 2009-06-01
- Completion
- 2011-01-01
- First posted
- 2009-05-21
- Last updated
- 2013-04-26
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT00905879. Inclusion in this directory is not an endorsement.